Defiance Daily Target 2X Long ORCL ETF
ORCX
0 hedge funds and large institutions have $0 invested in Defiance Daily Target 2X Long ORCL ETF in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
3.11% less ownership
Funds ownership: 3.11% → 0% (-3.1%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $211K → $0 (-$211K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$210K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.26K |
ORCX Hedge Fund Activity: Q2 2025 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Defiance Daily Target 2X Long ORCL ETF (ORCX) for Q2 2025, worth a combined $0 — down 100% from $211K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ORCX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Flow Traders U.S., exiting entirely with an estimated $210K sold.
- 0 institutional investors held Defiance Daily Target 2X Long ORCL ETF (ORCX) as of Q2 2025, down from 2 in Q1 2025.
- Funds reported $0 of Defiance Daily Target 2X Long ORCL ETF stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Defiance Daily Target 2X Long ORCL ETF positions in Q2 2025 and 2 closed out, a net change of -2 holders.
- The largest Defiance Daily Target 2X Long ORCL ETF seller in Q2 2025 was Flow Traders U.S., an estimated $210K sold.
Based on aggregated 13F filings for Q2 2025.